Sergio Sismondo

3.4k total citations · 1 hit paper
53 papers, 1.6k citations indexed

About

Sergio Sismondo is a scholar working on Pharmacology, Economics and Econometrics and History and Philosophy of Science. According to data from OpenAlex, Sergio Sismondo has authored 53 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Pharmacology, 15 papers in Economics and Econometrics and 11 papers in History and Philosophy of Science. Recurrent topics in Sergio Sismondo's work include Pharmaceutical industry and healthcare (24 papers), Pharmaceutical Economics and Policy (14 papers) and Philosophy and History of Science (8 papers). Sergio Sismondo is often cited by papers focused on Pharmaceutical industry and healthcare (24 papers), Pharmaceutical Economics and Policy (14 papers) and Philosophy and History of Science (8 papers). Sergio Sismondo collaborates with scholars based in Canada, United States and Netherlands. Sergio Sismondo's co-authors include Joel Lexchin, Andreas Lundh, Lisa Bero, Mathieu Doucet, Nicholas Chrisman, Matthew D. F. McInnes, Kristin Wright, Bishal Gyawali, Christopher M. Booth and Vinay Prasad and has published in prestigious journals such as SHILAP Revista de lepidopterología, Cochrane Database of Systematic Reviews and Social Science & Medicine.

In The Last Decade

Sergio Sismondo

49 papers receiving 1.5k citations

Hit Papers

Industry sponsorship and research outcome 2012 2026 2016 2021 2012 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Industry sponsorship and research outcome
    2012 454 citations Andreas Lundh, Sergio Sismondo et al. Cochrane Database of Systematic Reviews profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sergio Sismondo Canada 17 542 364 309 299 231 53 1.6k
Annette Flanagin United States 8 320 0.6× 101 0.3× 351 1.1× 325 1.1× 110 0.5× 51 1.4k
Elizabeth Wager United Kingdom 31 505 0.9× 506 1.4× 1.3k 4.3× 1.4k 4.6× 278 1.2× 106 4.3k
Matko Marušić Croatia 25 179 0.3× 75 0.2× 441 1.4× 893 3.0× 79 0.3× 180 2.7k
Jon F. Merz United States 32 303 0.6× 507 1.4× 80 0.3× 887 3.0× 232 1.0× 95 2.5k
Wendy Lipworth Australia 22 215 0.4× 399 1.1× 52 0.2× 569 1.9× 141 0.6× 167 1.7k
Elise Smith United States 15 91 0.2× 56 0.2× 263 0.9× 458 1.5× 73 0.3× 42 994
Grant Lewison United Kingdom 30 31 0.1× 329 0.9× 859 2.8× 558 1.9× 198 0.9× 118 2.5k
Christopher T. Robertson United States 22 148 0.3× 297 0.8× 43 0.1× 143 0.5× 168 0.7× 139 1.8k
Adam Hedgecoe United Kingdom 20 189 0.3× 129 0.4× 30 0.1× 414 1.4× 192 0.8× 42 1.4k
Gert Helgesson Sweden 29 61 0.1× 185 0.5× 192 0.6× 1.2k 4.1× 154 0.7× 134 2.5k

Countries citing papers authored by Sergio Sismondo

Since Specialization
Citations

This map shows the geographic impact of Sergio Sismondo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sergio Sismondo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sergio Sismondo more than expected).

Fields of papers citing papers by Sergio Sismondo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sergio Sismondo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sergio Sismondo. The network helps show where Sergio Sismondo may publish in the future.

Co-authorship network of co-authors of Sergio Sismondo

This figure shows the co-authorship network connecting the top 25 collaborators of Sergio Sismondo. A scholar is included among the top collaborators of Sergio Sismondo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sergio Sismondo. Sergio Sismondo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sismondo, Sergio, et al.. (2025). How big is the medical writing industry? Why it matters. Health Promotion International. 40(5).
2.
Sismondo, Sergio, et al.. (2024). How an opioid giant deployed a playbook for moulding doctors’ minds. BMJ. 385. q1208–q1208. 2 indexed citations
3.
Sismondo, Sergio, et al.. (2024). Promoting opioids, a story about how to influence medical science and opinions. Frontiers in Medicine. 11. 1327939–1327939. 4 indexed citations
4.
Sismondo, Sergio. (2023). Le management fantôme de la médecine. ENS Éditions eBooks.
5.
Sismondo, Sergio, et al.. (2022). Political Prescriptions: Three Pandemic Stories. Science Technology & Human Values. 49(2). 371–402. 7 indexed citations
6.
Sismondo, Sergio. (2021). Epistemic Corruption, the Pharmaceutical Industry, and the Body of Medical Science. SHILAP Revista de lepidopterología. 6. 614013–614013. 29 indexed citations
7.
Sismondo, Sergio. (2020). Access to Medicines, Access to Markets. Frontiers in Sociology. 5. 58–58. 3 indexed citations
8.
Sismondo, Sergio. (2018). Ghost-Managed Medicine. 62 indexed citations
9.
Sismondo, Sergio. (2015). Ontological turns, turnoffs and roundabouts. Social Studies of Science. 45(3). 441–448. 21 indexed citations
10.
Sismondo, Sergio. (2013). Key Opinion Leaders and the Corruption of Medical Knowledge: What the Sunshine Act Will and Won’t Cast Light on. The Journal of Law Medicine & Ethics. 41(3). 635–643. 4 indexed citations
11.
Lundh, Andreas, et al.. (2012). Industry sponsorship and research outcome. Cochrane Database of Systematic Reviews. 12. MR000033–MR000033. 454 indexed citations breakdown →
12.
Sismondo, Sergio & Mathieu Doucet. (2009). PUBLICATION ETHICS AND THE GHOST MANAGEMENT OF MEDICAL PUBLICATION. Bioethics. 24(6). 273–283. 43 indexed citations
13.
Sismondo, Sergio. (2008). How Pharmaceutical Industry Funding Affects Trial Outcomes: Causal Structures and Responses. SSRN Electronic Journal. 2 indexed citations
14.
Sismondo, Sergio. (2008). How pharmaceutical industry funding affects trial outcomes: Causal structures and responses. Social Science & Medicine. 66(9). 1909–1914. 131 indexed citations
15.
Sismondo, Sergio. (2007). Pharmaceutical company funding and its consequences: A qualitative systematic review. Contemporary Clinical Trials. 29(2). 109–113. 7 indexed citations
16.
Sismondo, Sergio. (2007). Ghost Management: How Much of the Medical Literature Is Shaped Behind the Scenes by the Pharmaceutical Industry?. PLoS Medicine. 4(9). e286–e286. 154 indexed citations
17.
Sismondo, Sergio. (2005). Boundary Work and the Science Wars: James Robert Brown'sWho Rules in Science?. Episteme. 1(3). 235–248. 2 indexed citations
18.
Sismondo, Sergio. (2004). Pharmaceutical Maneuvers. Social Studies of Science. 34(2). 149–159. 16 indexed citations
19.
Sismondo, Sergio, et al.. (1998). The Mapping Metaphor in Philosophy of Science. 12(1). 41–50. 2 indexed citations
20.
Sismondo, Sergio. (1993). Some Social Constructions. Social Studies of Science. 23(3). 515–553. 146 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Annette Flanagin Breakdown of academic impact, for papers by Elizabeth Wager Breakdown of academic impact, for papers by Matko Marušić Breakdown of academic impact, for papers by Jon F. Merz Breakdown of academic impact, for papers by Wendy Lipworth Breakdown of academic impact, for papers by Elise Smith Breakdown of academic impact, for papers by Grant Lewison Breakdown of academic impact, for papers by Christopher T. Robertson Breakdown of academic impact, for papers by Adam Hedgecoe Breakdown of academic impact, for papers by Gert Helgesson
Rankless by CCL
2026